MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
-$7,144,843
Free Cash flow
$130,457
Unit: Dollar
Positive Cash Flow Breakdown
Accounts payable and other curre...
Accounts receivable
Other long-term liabilities
Others
Negative Cash Flow Breakdown
Payments on line of credit
Net (increase) decrease of inves...
Depreciation and amortization ex...
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net income (loss)
-4,274,430
-3,287,051
-1,428,642
-1,949,046
Depreciation and amortization expense
-1,204,664
1,276,283
1,041,895
1,037,804
Amortization of operating lease right-of-use asset
196,139
285,184
285,185
285,184
Loss on co-commercialization investment
-
-
-13,220
-
Disposal of assets
-
-
0
-
Co-commercialization investment loss
-
-146,080
-
-
Share-based compensation
77,866
106,842
172,160
81,262
Increase (decrease) in non-cash contingent consideration
-
-228,965
-46,660
9,651
Increase in cash surrender value of life insurance policies over premiums paid
253,211
-86,949
10,960
91,460
Noncash interest expense
-
5,173
7,100
5,362
Loss on disposal of assets
-
-
-
0
Life insurance proceeds
-
-
0
0
Accounts receivable
-842,384
-2,682,802
6,514,178
113,691
Inventories, net
703,861
-703,861
205,989
-630,409
Other current assets and other assets
427,093
-384,152
1,050,788
-178,936
Operating lease liabilities
-226,851
-225,351
-173,983
-221,675
Accounts payable and other current liabilities
1,454,343
-1,346,113
8,043,897
684,224
Other long-term liabilities
557,170
-202,821
-129,233
-349,780
Net cash provided by (used in) operating activities from continuing operations
-3,497,471
-
-
-
Discontinued operations
4,053,236
-
-
-
Net cash provided by operating activities
168,740
387,025
3,024
187,180
Additions to property and equipment
38,283
0
-1
23,788
Net investment in manufacturing
-
-
1,029,497
611,600
Life insurance policy proceeds received
-
-
0
0
Other investment
-
-
2,000,000
-
Investment in cash surrender value of life insurance policies
0
42,018
0
47,000
Net (increase) decrease of investment in manufacturing
1,754,228
0
-
-
Additions to intangible assets
-11,552
19,155
43,842
8,449
Net cash used in investing activities from continuing operations
-1,842,132
-
-
-
Discontinued operations
-145,459
-
-
-
Net cash used in investing activities
-1,926,418
-61,173
-3,073,338
-690,837
Proceeds from atm offering, net
0
0
0
0
Borrowings on line of credit
-
-
0
0
Payments on line of credit
5,240,733
0
0
0
Cash settlement of contingent consideration
-
702,299
681,738
376,440
Payments made in connection with repurchase of common shares
0
61,001
0
10,439
Net cash used in financing activities from continuing operations
-5,301,734
-
-
-
Discontinued operations
-848,731
-
-
-
Net cash used in financing activities
-5,387,165
-763,300
-681,738
-386,879
Net decrease in cash and cash equivalents
-7,144,843
-437,448
-3,752,052
-890,536
Cash and cash equivalents at beginning of period
11,007,245
11,444,693
15,196,745
17,964,184
Cash and cash equivalents at end of period
3,862,402
11,007,245
11,444,693
15,196,745
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Discontinued operations
$4,053,236
Net cash provided by
operating activities
$168,740
(-96.44%↓ Y/Y)
Canceled cashflow
$3,884,496
Accounts payable and
other current...
$1,454,343
(172.04%↑ Y/Y)
Accounts receivable
-$842,384
(39.16%↑ Y/Y)
Other long-term
liabilities
$557,170
(40539.68%↑ Y/Y)
something is missing
$464,737
Amortization of operating
lease right-of-use...
$196,139
(-65.61%↓ Y/Y)
Share-based compensation
$77,866
(-49.73%↓ Y/Y)
Net decrease in cash
and cash...
-$7,144,843
(-280.67%↓ Y/Y)
Canceled cashflow
$168,740
something is missing
$763,300
Net cash provided by
(used in) operating...
-$3,497,471
something is missing
-$387,025
Canceled cashflow
$3,592,639
Net cash used in
financing activities
-$5,387,165
(5.10%↑ Y/Y)
Net cash used in
investing activities
-$1,926,418
(-104.43%↓ Y/Y)
Canceled cashflow
$763,300
Net income (loss)
-$4,274,430
(-933.26%↓ Y/Y)
Depreciation and
amortization expense
-$1,204,664
(-158.32%↓ Y/Y)
Inventories, net
$703,861
(138.71%↑ Y/Y)
Other current assets
and other assets
$427,093
(166.73%↑ Y/Y)
Increase in cash
surrender value of life...
$253,211
(525.10%↑ Y/Y)
Operating lease
liabilities
-$226,851
(48.49%↑ Y/Y)
Net cash used in
financing activities from...
-$5,301,734
Discontinued operations
-$848,731
Net cash used in
investing activities from...
-$1,842,132
Discontinued operations
-$145,459
Payments on line of credit
$5,240,733
(-47.78%↓ Y/Y)
Net (increase)
decrease of investment in...
$1,754,228
Additions to property and
equipment
$38,283
(-48.35%↓ Y/Y)
Buy us a coffee
CUMBERLAND PHARMACEUTICALS INC (CPIX)
CUMBERLAND PHARMACEUTICALS INC (CPIX)